Clinical · Molecular biology · Bioinfo & AI
Delineating SWI/SNF gene and subtype expression in cancer
This study investigated the expression of SWI/SNF chromatin remodeling complex genes and its subtypes (cBAF, PBAF, GBAF) across 33 tumor types, utilizing DNA and mRNA data from The Cancer Genome Atlas (approximately 11,000 samples). Researchers found that the expression of certain genes like ACTL6B, DPF1, DPF3, and SMARCD3 varied most among tumor types, with 10 out of 33 tumor types exhibiting distinct expression signatures. While SWI/SNF gene mutations resulted in only minor changes in their own expression, they were linked to downstream regulation of transcriptional programs associated with epigenetic regulation, particularly in colon adenocarcinoma, kidney renal clear cell carcinoma, stomach adenocarcinoma, and uterine corpus endometrial carcinoma. These findings could contribute to the development of biomarkers and targeted therapies.